Low-dose ionising radiation and cardiovascular diseases - Strategies for molecular epidemiological studies in Europe

Mutation Research - Reviews in Mutation Research

Volumn 764, Issue , 2015, Pages 90-100

  Kreuzer, Michaela ^a   Auvinen, Anssi ^b,c   Cardis, Elisabeth ^d   Hall, Janet ^e,k   Jourdain, Jean Rene ^f   Laurier, Dominique ^f   Little, Mark P ^g   Peters, Annette ^h   Raj, Ken ⁱ   Russell, Nicola S ^j   Tapio, Soile ^h   Zhang, Wei ⁱ   Gomolka, Maria ^a  

^a BUNDESAMT FÜR STRAHLENSCHUTZ   (Germany)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^c STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^d UNIVERSITAT POMPEU FABRA   (Spain)

^e INSERM U612   (France)

^f INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

^g NATIONAL CANCER INSTITUTE   (United States)

^h INSTITUTE OF EPIDEMIOLOGY   (Germany)

ⁱ PUBLIC HEALTH ENGLAND   (United Kingdom)

^j NETHERLANDS CANCER INSTITUTE   (Netherlands)

^k CNRS   (France)

more..

Author keywords

Biomarker; Cardiovascular diseases; Epidemiology; Ionising radiation; Pathogenesis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; TROPONIN I;

ALCOHOL CONSUMPTION; ATHEROSCLEROSIS; ATOMIC BOMB SURVIVOR; BLOOD VESSEL INJURY; BREAST CANCER; CANCER RADIOTHERAPY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CHERNOBYL LIQUIDATOR; CHILDHOOD CANCER; CHRONIC KIDNEY DISEASE; FLUOROSCOPY; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEART INFARCTION; HEART MUSCLE FIBROSIS; HODGKIN DISEASE; HUMAN; IONIZING RADIATION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; LOW ENERGY RADIATION; MAYAK WORKER; MICROVASCULAR DAMAGE; MOLECULAR EPIDEMIOLOGY; MORTALITY; NAMED GROUPS BY OCCUPATION; NONHUMAN; NUCLEAR WORKER; OCCUPATIONAL EXPOSURE; PARTIAL BODY RADIATION; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION INDUCED NEOPLASM; RADIATION INJURY; RADIATION PROTECTION; REVIEW; RISK FACTOR; SMOKING; TECHA RIVER RESIDENT; URANIUM MINE; WHOLE BODY RADIATION; ADVERSE EFFECTS; CARDIOTOXICITY; CARDIOVASCULAR DISEASES; CHERNOBYL ACCIDENT; ENVIRONMENTAL EXPOSURE; EUROPE; RADIATION RESPONSE; RISK ASSESSMENT;

CARDIOTOXICITY; CARDIOVASCULAR DISEASES; CHERNOBYL NUCLEAR ACCIDENT; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENVIRONMENTAL EXPOSURE; EUROPE; HUMANS; RADIATION, IONIZING; RISK ASSESSMENT;

EID: 84930045539     PISSN: 13835742     EISSN: 13882139     Source Type: Journal    
DOI: 10.1016/j.mrrev.2015.03.002     Document Type: Review

References (135)

1. Adams M.J., Hardenbergh P.H., Constine L.S., Lipshultz S.E. Radiation-associated cardiovascular disease. Crit. Rev. Oncol. Hematol. 2003, 45:55-75.
2. Schultz-Hector S., Trott K.R. Radiation-induced cardiovascular diseases: is the epidemiologic evidence compatible with the radiobiologic data?. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:10-18.
3. Stewart F.A., Hoving S., Russell N.S. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat. Res. 2010, 174:865-869.
4. AGIR (Advisory Group on Ionising Radiation) Circulatory Disease Risk. Report of the Independent Advisory Group on Ionizing Radiation 2010, Health Protection Agency, London.
5. Hendry J.H., Akahoshi M., Wang L.S., Lipshultz S.E., Stewart F.A., Trott K.R. Radiation-induced cardiovascular injury. Radiat. Environ. Biophys. 2008, 47:189-193.
6. ICRP, International Commission on Radiation Protection ICRP PUBLICATION 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs - threshold doses for tissue reactions in a radiation protection context. Ann. ICRP 2012, 41:1-2.
7. Little M.P., Azizova T.V., Bazyka D., Bouffler S.D., Cardis E., Chekin S., Chumak V.V., Cucinotta F.A., de Vathaire F., Hall P., Harrison J.D., Hildebrandt G., Ivanov V., Kashcheev V.V., Klymenko S.V., Kreuzer M., Laurent O., Ozasa K., Schneider T., Tapio S., Taylor A.M., Tzoulaki I., Vandoolaeghe W.L., Wakeford R., Zablotska L.B., Zhang W., Lipshultz S.E. Systematic review and meta-analysis of circulatory disease from exposure to low-level ionizing radiation and estimates of potential population mortality risks. Environ. Health Perspect. 2012, 120:1503-1511.
8. Shimizu Y., Kodama K., Nishi N., Kasagi F., Suyama A., Soda M., Grant E.J., Sugiyama H., Sakata R., Moriwaki H., Hayashi M., Konda M., Shore R.E. Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950-2003. BMJ 2010, 340:b5349.
9. Yamada M., Wong F.L., Fujiwara S., Akahoshi M., Suzuki G. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat. Res. 2004, 161:622-632.
10. Ivanov V.K., Maksioutov M.A., Chekin S.Y., Petrov A.V., Biryukov A.P., Kruglova Z.G., Matyash V.A., Tsyb A.F., Manton K.G., Kravchenko J.S. The risk of radiation-induced cerebrovascular disease in Chernobyl emergency workers. Health Phys. 2006, 90:199-207.
11. Azizova T.V., Muirhead C.R., Moseeva M.B., Grigoryeva E.S., Sumina M.V., O'Hagan J., Zhang J.W., Haylock R.J., Hunter N. Cerebrovascular diseases in nuclear workers first employed at the Mayak PA in 1948-1972. Radiat. Environ. Biophys. 2011, 50:539-552.
12. Azizova T.V., Muirhead C.R., Moseeva M.B., Grigoryeva E.S., Vlasenko E.V., Hunter N., Haylock R.G., O'Hagan J.A. Ischemic heart disease in nuclear workers first employed at the Mayak PA in 1948-1972. Health Phys. 2012, 103:3-14.
13. Azizova T.V., Haylock R.G.E., Moseeva M.B., Bannikova M.V., Grigoryeva E.S. Cerebrovascular diseases incidence and mortality in an extended Mayak Worker Cohort 1948-1982. Radiat. Res. 2014, 182:529-544.
14. Moseeva M.B., Azizova T.V., Grigoryeva E.S., Haylock R. Risks of circulatory diseases among Mayak PA workers with radiation doses estimated using the improved Mayak Worker Dosimetry System 2008. Radiat. Environ. Biophys. 2014, 53:469-477.
15. Little M.P., Tawn E.J., Tzoulaki I., Wakeford R., Hildebrandt G., Paris F., Tapio S., Elliott P. A systematic review of epidemiological associations between low and moderate doses of ionizing radiation and late cardiovascular effects, and their possible mechanisms. Radiat. Res. 2008, 169:99-109.
16. Little M.P., Tawn E.J., Tzoulaki I., Wakeford R., Hildebrandt G., Paris F., Tapio S., Elliott P. Review and meta-analysis of epidemiological associations between low/moderate doses of ionizing radiation and circulatory disease risks, and their possible mechanisms. Radiat. Environ. Biophys. 2010, 49:139-153.
17. Little M.P. A review of non-cancer effects, especially circulatory and ocular diseases. Radiat. Environ. Biophys. 2013, 52:435-449.
18. McGeoghegan D., Binks K., Gillies M., Jones S., Whaley S. The non-cancer mortality experience of male workers at British Nuclear Fuels plc, 1946-2005. Int. J. Epidemiol. 2008, 37:506-518.
19. Muirhead C.R., O'Hagan J.A., Haylock R.G., Phillipson M.A., Willcock T., Berridge G.L., Zhang W. Mortality and cancer incidence following occupational radiation exposure: third analysis of the National Registry for Radiation Workers. Br. J. Cancer 2009, 100:206-212.
20. Hildebrandt G. Non-cancer diseases and non-targeted effects. Mutat. Res. 2010, 687:73-77.
21. Pernot E., Hall J., Baatout S., Benotmane M.A., Blanchardon E., Bouffler S., El Saghire H., Gomolka M., Guertler A., Harms-Ringdahl M., Jeggo P., Kreuzer M., Laurier D., Lindholm C., Mkacher R., Quintens R., Rothkamm K., Sabatier L., Tapio S., de Vathaire F., Cardis E. Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat. Res. 2012, 751:258-286.
22. Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128.
23. Murray C.J., Vos T., Lozano R., Naghavi M., Flaxman A.D., Michaud C., et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223.
24. Tunstall-Pedoe H., Vanuzzo D., Hobbs M., Mahonen M., Cepaitis Z., Kuulasmaa K., et al. Estimation of contribution of changes in coronary care to improving survival, event rates, and coronary heart disease mortality across the WHO MONICA Project populations. Lancet 2000, 355:688-700.
25. Kuch B., Heier M., von Scheidt W., Kling B., Hoermann A., Meisinger C. 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985-2004). J. Intern. Med. 2010, 264:254-264.
26. Peeters A., Nusselder W.J., Stevenson C., Boyko E.J., Moon L., Tonkin A. Age-specific trends in cardiovascular mortality rates in the Netherlands between 1980 and 2009. Eur. J. Epidemiol. 2011, 26:369-373.
27. Piotrowski W., Polakowska M., Koziarek J., Broda G. Sudden cardiovascular death rate and ischaemic heart disease death rate changes during the 5-year period of 2003-2008. Kardiol. Pol. 2012, 70:1225-1234.
28. Alpert J.S., Thygesen K., White H.D., Jaffe A.S. Implications of the universal definition of myocardial infarction. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:678-679.
29. Lim S.S., Vos T., Flaxman A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260.
30. Anderson K.M., Wilson P.W., Odell P.M., Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 1991, 83:356-362.
31. Schunkert H., Erdmann J., Samani N.J. Genetics of myocardial infarction: a progress report. Eur. Heart J. 2010, 31:918-925.
32. Grundy S.M., Brewer H.B., Cleeman J.L., Smith S.C., Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433-438.
33. Blankenberg S., Zeller T., Saarela O., Havulinna A.S., Kee F., Tunstall-Pedoe H., Kuulasmaa K., Yarnell J., Schnabel R.B., Wild P.S., Münzel T.F., Lackner K.J., Tiret L., Evans A., Salomaa V., MORGAM Project Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph (MORGAM) biomarker project. Circulation 2010, 121:2388-2397.
34. Bonaterra G.A., Zugel S., Kinscherf R. Novel systemic cardiovascular disease biomarkers. Curr. Mol. Med. 2010, 10:180-205.
35. Danesh J., Wheeler J.G., Hirschfield G.M., Eda S., Eiriksdottir G., Rumley A., Lowe G.D., Pepys M.B., Gudnason V. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 2004, 350:1387-1397.
36. Jensen M.K., Bertoia M.L., Cahill L.E., Agarwal I., Rimm E.B., Mukamal K.J. Novel metabolic biomarkers of cardiovascular disease. Nat. Rev. Endocrinol. 2014, 10:659-672.
37. Singh V., Martinezclark P., Pascual M., Shaw E.S., O'Neill W.W. Cardiac biomarkers - the old and the new: a review. Coron. Artery Dis. 2010, 21:244-256.
38. Deloukas P., Kanoni S., Willenborg C., Farrall M., Assimes T.L., Thompson J.R., et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 2013, 45:25-33.
39. Lieb W., Jansen H., Loley C., Pencina M.J., Nelson C.P., Newton-Cheh C., Kathiresan S., Reilly M.P., Assimes T.L., Boerwinkle E., Hall A.S., Hengstenberg C., Laaksonen R., McPherson R., Thorsteinsdottir U., Ziegler A., Peters A., Thompson J.R., König I.R., Erdmann J., Samani N.J., Vasan R.S., Schunkert H., CARDIoGRAM Genetic predisposition to higher blood pressure increases coronary artery disease risk. Hypertension 2013, 61:995-1001.
40. Darby S.C., Cutter D.J., Boerma M., Constine L.S., Fajardo L.F., Kodama K., Mabuchi K., Marks L.B., Mettler F.A., Pierce L.J., Trott K.R., Yeh E.T., Shore R.E. Radiation-related heart disease: current knowledge and future prospects. Int. J. Radiat. Oncol. Biol. Phys. 2010, 76:656-665.
41. Hancock S.L., Tucker M.A., Hoppe R.T. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease. JAMA 1993, 270:1949-1955.
42. Darby S.C., Ewertz M., McGale P., Bennet A.M., Blom-Goldman U., Bronnum D., Correa C., Cutter D., Gagliardi G., Gigante B., Jensen M.B., Nisbet A., Peto R., Rahimi K., Taylor C., Hall P. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N. Engl. J. Med. 2013, 368:987-998.
43. Mulrooney D.A., Yeazel M.W., Kawashima T., Mertens A.C., Mitby P., Stovall M., Donaldson S.S., Green D.M., Sklar C.A., Robison L.L., Leisenring W.M. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009, 339:b4606. 10.1136/bmj.b4606.
44. Taylor C.W., Brønnum D., Darby S.C., Gagliardi G., Hall P., Jensen M.B., McGale P., Nisbet A., Ewertz M. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001. Radiother. Oncol. 2011, 100:176-183.
45. Preston D.L., Shimizu Y., Pierce D.A., Suyama A., Mabuchi K. Studies of mortality of atomic bomb survivors. Report 13: Solid cancer and noncancer disease mortality: 1950-1997. Radiat. Res. 2003, 160:381-407.
46. Ozasa K., Shimizu Y., Suyama A., Kasagi F., Soda M., Grant E.J., Sakata R., Sugiyama H., Kodama K. Studies of the mortality of atomic bomb survivors, Report 14, 1950-2003: an overview of cancer and noncancer diseases. Radiat. Res. 2012, 177:229-243.
47. Takahashi I., Abbott R.D., Ohshita T., Takahashi T., Ozasa K., Akahoshi M., Fujiwara S., Kodama K., Matsumoto M. A prospective follow-up study of the association of radiation exposure with fatal and non-fatal stroke among atomic bomb survivors in Hiroshima and Nagasaki (1980-2003). BMJ Open 2012, 2:e000654.
48. Sasaki H., Wong F.L., Yamada M., Kodama K. The effects of aging and radiation exposure on blood pressure levels of atomic bomb survivors. J. Clin. Epidemiol. 2002, 55:974-981.
49. Wong F.L., Yamada M., Sasaki H., Kodama K., Hosoda Y. Effects of radiation on the longitudinal trends of total serum cholesterol levels in the atomic bomb survivors. Radiat. Res. 1999, 151:736-746.
50. Yamada M., Naito K., Kasagi F., Masunari N., Suzuki G. Prevalence of atherosclerosis in relation to atomic bomb radiation exposure: an RERF Adult Health Study. Int. J. Radiat. Biol. 2005, 81:821-826.
51. Adams M.J., Grant E.J., Kodama K., Shimizu Y., Kasagi F., Suyama A., Sakata R., Akahoshi M. Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation. Radiat. Res. 2012, 177:220-228.
52. Hakoda M., Kasagi F., Kusunoki Y., Matsuura S., Hayashi T., Kyoizumi S., Akahoshi M., Suzuki G., Kodama K., Fujiwara S. Levels of antibodies to microorganisms implicated in atherosclerosis and of C-reactive protein among atomic bomb survivors. Radiat. Res. 2006, 166:360-366.
53. Hayashi T., Morishita Y., Khattree R., Misumi N., Sasaki K., Hayashi I., Yoshida K., Kajimura J., Kyoizumi S., Imai K., Kusunoki Y., Nakachi K. Evaluation of systemic markers of inflammation in atomic-bomb survivors with special reference to radiation and age effects. FASEB J. 2012, 26:4765-4773.
54. Hayashi T., Morishita Y., Kubo Y., Kusunoki Y., Hayashi I., Kasagi F., Hakoda M., Kyoizumi S., Nakachi K. Long-term effects of radiation dose on inflammatory markers in atomic bomb survivors. Am. J. Med. 2005, 118:83-86.
55. Guseva Canu I., Garsi J.P., Caer-Lorho S., Jacob S., Collomb P., Acker A., Laurier D. Does uranium induce circulatory diseases? First results from a French cohort of uranium workers. Occup. Environ. Med. 2012, 69:404-409.
56. Kreuzer M., Dufey F., Sogl M., Schnelzer M., Walsh L. External gamma radiation and mortality from cardiovascular diseases in the German WISMUT uranium miners cohort study, 1946-2008. Radiat. Environ. Biophys. 2013, 52:37-46.
57. Kreuzer M., Kreisheimer M., Kandel M., Schnelzer M., Tschense A., Grosche B. Mortality from cardiovascular diseases in the German uranium miners cohort study, 1946-1998. Radiat. Environ. Biophys. 2006, 45:159-166.
58. Lane R.S., Frost S.E., Howe G.R., Zablotska L.B. Mortality (1950-1999) and cancer incidence (1969-1999) in the cohort of Eldorado uranium workers. Radiat. Res. 2010, 174:773-785.
59. Laurent O., Metz-Flamant C., Rogel A., Hubert D., Riedel A., Garcier Y., Laurier D. Relationship between occupational exposure to ionizing radiation and mortality at the French electricity company, period 1961-2003. Int. Arch. Occup. Environ. Health 2010, 83:935-944.
60. Metz-Flamant C., Laurent O., Samson E., Caër-Lorho S., Acker A., Hubert D., Richardson D.B., Laurier D. Mortality associated with chronic external radiation exposure in the French combined cohort of nuclear workers. Occup. Environ. Med. 2013, 70:630-638.
61. Vrijheid M., Cardis E., Ashmore P., Auvinen A., Bae J.M., Engels H., Gilbert E., Gulis G., Habib R., Howe G., Kurtinaitis J., Malker H., Muirhead C., Richardson D., Rodriguez-Artalejo F., Rogel A., Schubauer-Berigan M., Tardy H., Telle-Lamberton M., Usel M., Veress K. Mortality from diseases other than cancer following low doses of ionizing radiation: results from the 15-Country Study of nuclear industry workers. Int. J. Epidemiol. 2007, 36:1126-1135.
62. Grosche B., Lackland D.T., Land C.E., Simon S.L., Apsalikov K.N., Pivina L.M., Bauer S., Gusev B.I. Mortality from cardiovascular diseases in the Semipalatinsk historical cohort, 1960-1999, and its relationship to radiation exposure. Radiat. Res. 2011, 176:660-669.
63. Talbott E.O., Youk A.O., McHugh-Pemu K.P., Zborowski J.V. Long-term follow-up of the residents of the Three Mile Island accident area: 1979-1998. Environ. Health Perspect. 2003, 111:341-348.
64. Little M.P., Kleinerman R.A., Stovall M., Smith S.A., Mabuchi K. Analysis of dose response for circulatory disease after radiotherapy for benign disease. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84:1101-1109.
65. Boekel N.B., Schaapveld M., Gietema J.A., Rutgers E.J., Versteegh M.I., Visser O., Aleman B.M., van Leeuwen F.E. Cardiovascular morbidity and mortality after treatment for ductal carcinoma in situ of the breast. J. Natl. Cancer Inst. 2014, 106(8). pii:dju156. 10.1093/jnci/dju156.
66. Darby S.C., Doll R., Gill S.K., Smith P.G. Long term mortality after a single treatment course with X-rays in patients treated for ankylosing spondylitis. Br. J. Cancer 1987, 55:179-190.
67. Zablotska L.B., Little M.P., Cornett R.J. Potential increased risk of ischemic heart disease mortality with significant dose fractionation in the Canadian Fluoroscopy Cohort Study. Am. J. Epidemiol. 2014, 179:120-131.
68. Davis F.G., Boice J.D., Hrubec Z., Monson R.R. Cancer mortality in a radiation-exposed cohort of Massachusetts tuberculosis patients. Cancer Res. 1989, 49:6130-6136.
69. Villeneuve P.J., Lane R.S.D., Morrison H.I. Coronary heart disease mortality and radon exposure in the Newfoundland fluorspar miners' cohort, 1950-2001. Radiat. Environ. Biophys. 2007, 46:291-296.
70. Nusinovici S., Vacquier B., Leurand K., Metz-Flamant C., Caer-Lorho S., Acker A., Laurier D. Mortality from circulatory system diseases and low-level radon exposure in the French cohort study of uranium miners, Scand. J. Work Environ. Health 2010, 36:373-383.
71. Rage E., Caër-Lorho S., Drubay D., Ancelet S., Laroche P., Laurier D. Mortality analyses in the updated French cohort of uranium miners (1946-2007). Int. Arch. Occup. Environ. Health 2014, 1-14.
72. Marsh J.W., Blanchardon E., Gregoratto D., Hofmann W., Karcher K., Nosske D., Tomásek L. Dosimetric calculations for uranium miners for epidemiological studies. Radiat. Prot. Dosim. 2012, 149:371-383.
73. Krestinina L.Y., Epifanova S., Silkin S., Mikryukova L., Degteva M., Shagina N., Akleyev A. Chronic low-dose exposure in the Techa River Cohort: risk of mortality from circulatory diseases. Radiat. Environ. Biophys. 2013, 52:47-57.
74. Stewart F.A., Seemann I., Hoving S., Russell N.S. Understanding radiation-induced cardiovascular damage and strategies for intervention. Clin. Oncol. 2013, 25:617-624.
75. Lusis A.J. Atherosclerosis. Nature 2000, 407:233-241.
76. Aleman B.M., van den Belt-Dusebout A.W., De Bruin M.L., van't Veer M.B., Baaijens M.H., de Boer J.P., Hart A.A., Klokman W.J., Kuenen M.A., Ouwens G.M., Bartelink H., van Leeuwen F.E. Late cardiotoxicity after treatment for Hodgkin lymphoma. Blood 2007, 109:1878-1886.
77. Dorresteijn L.D., Kappelle A.C., Boogerd W., Klokman W.J., Balm A.J., Keus R.B., van Leeuwen F.E., Bartelink H. Increased risk of ischemic stroke after radiotherapy on the neck in patients younger than 60 years. J. Clin. Oncol. 2002, 20:282-288.
78. Russell N.S., Hoving S., Heeneman S., Hage J.J., Woerdeman L.A., de Bree R., Lohuis P.J., Smeele L., Cleutjens J., Valenkamp A., Dorresteijn L.D., Dalesio O., Daemen M.J., Stewart F.A. Novel insights into pathological changes in muscular arteries of radiotherapy patients. Radiother. Oncol. 2009, 92:477-483.
79. Hewitt G., Jurk D., Marques F.D., Correia-Melo C., Hardy T., Gackowska A., Anderson R., Taschuk M., Mann J., Passos J.F. Telomeres are favoured targets of a persistent DNA damage response in ageing and stress-induced senescence. Nat. Commun. 2012, 3:708.
80. Lowe D., Raj K. Premature aging induced by radiation exhibits pro-atherosclerotic effects mediated by epigenetic activation of CD44 expression. Aging Cell 2014, 13:900-910.
81. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
82. Vasile E., Tomita Y., Brown L.F., Kocher O., Dvorak H.F. Differential expression of thymosin beta-10 by early passage and senescent vascular endothelium is modulated by VPF/VEGF: evidence for senescent endothelial cells in vivo at sites of atherosclerosis. FASEB J. 2001, 15:458-466.
83. Rombouts C., Aerts A., Quintens R., Baselet B., El-Saghire H., Harms-Ringdahl M., Haghdoost S., Janssen A., Michaux A., Yentrapalli R., Benotmane M.A., Van Oostveldt P., Baatout S. Transcriptomic profiling suggests a role for IGFBP5 in premature senescence of endothelial cells after chronic low dose rate irradiation. Int. J. Radiat. Biol. 2014, 90:560-574.
84. Yentrapalli R., Azimzadeh O., Barjaktarovic Z., Sarioglu H., Wojcik A., Harms-Ringdahl M., Atkinson M.J., Haghdoost S., Tapio S.S. Quantitative proteomic analysis reveals induction of premature senescence in human umbilical vein endothelial cells exposed to chronic low-dose rate gamma radiation. Proteomics 2013, 13:1096-1107.
85. Yentrapalli R., Azimzadeh O., Sriharshan A., Malinowsky K., Merl J., Wojcik A., Harms-Ringdahl M., Atkinson M.J., Becker K.F., Haghdoost S., Tapio S.S. The PI3K/Akt/mTOR pathway is implicated in the premature senescence of primary human endothelial cells exposed to chronic radiation. PLOS ONE 2013, 8:e70024. 10.1371/journal.pone.0070024.
86. Hoving S., Heeneman S., Gijbels M.J., Te Poele J.A., Visser N., Cleutjens J., Russell N.S., Daemen M.J., Stewart F.A. Irradiation induces different inflammatory and thrombotic responses in carotid arteries of wildtype C57BL/6J and atherosclerosis-prone ApoE(-/-) mice. Radiother. Oncol. 2012, 105:365-370.
87. Stewart F.A., Heeneman S., Te Poele J., Kruse J., Russell N.S., Gijbels M.M., Daemen M. Ionizing radiation accelerates the development of atherosclerotic lesions in ApoE-/- mice and predisposes to an inflammatory plaque phenotype prone to hemorrhage. Am. J. Pathol. 2006, 168:649-658.
88. Vos J., Aarnoudse M.W., Dijk F., Lamberts H.B. On the cellular origin and development of atheromatous plaques. A light and electron microscopic study of combined X-ray and hypercholesterolemia-induced atheromatosis in the carotid artery of the rabbit. Virchows Arch. B: Cell Pathol. Incl. Mol. Pathol. 1983, 43:1-16.
89. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
90. Hoving S., Heeneman S., Gijbels M.J., te Poele J.A., Bolla M., Pol J.F., Simons M.Y., Russell N.S., Daemen M.J., Stewart F.A. NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice. PLoS ONE 2010, 5:e12874. 10.1371/journal.pone.0012874.
91. Hoving S., Heeneman S., Gijbels M.J., te Poele J.A., Pol J.F., Gabriels K., Russell N.S., Daemen M.J., Stewart F.A. Anti-inflammatory and anti-thrombotic intervention strategies using atorvastatin, clopidogrel and knock-down of CD40L do not modify radiation-induced atherosclerosis in ApoE null mice. Radiother. Oncol. 2011, 101:100-108.
92. Turesson I. The progression rate of late radiation effects in normal tissue and its impact on dose-response relationships. Radiother. Oncol. 1989, 15:217-226.
93. Wachter S., Gerstner N., Goldner G., Potzi R., Wambersie A., Potter R. Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. Radiother. Oncol. 2001, 59:65-70.
94. Turesson I. Individual variation and dose dependency in the progression rate of skin telangiectasia. Int. J. Radiat. Oncol. Biol. Phys. 1990, 19:1569-1574.
95. Barcellos-Hoff M.H. Stromal mediation of radiation carcinogenesis. J. Mammary Gland Biol. Neoplasia 2010, 15:381-387.
96. de Cortie K., Russell N.S., Coppes R.P., Stewart F.A., Scharpfenecker M. Bone marrow-derived macrophages incorporate into the endothelium and influence vascular and renal function after irradiation. Int. J. Radiat. Biol. 2014, 90:769-777.
97. Scharpfenecker M., Floot B., Korlaar R., Russell N.S., Stewart F.A. ALK1 heterozygosity delays development of late normal tissue damage in the irradiated mouse kidney. Radiother. Oncol. 2011, 99:349-355.
98. Scharpfenecker M., Floot B., Russell N.S., Coppes R.P., Stewart F.A. Endoglin haploinsufficiency attenuates radiation-induced deterioration of kidney function in mice. Radiother. Oncol. 2013, 108:464-468.
99. Scharpfenecker M., Floot B., Russell N.S., Stewart F.A. The TGF-beta co-receptor endoglin regulates macrophage infiltration and cytokine production in the irradiated mouse kidney. Radiother. Oncol. 2012, 105:313-320.
100. Michalowski A.S. On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs. Acta Oncol. 1994, 33:139-157.
101. Siegal T., Pfeffer M.R. Radiation-induced changes in the profile of spinal cord serotonin, prostaglandin synthesis, and vascular permeability. Int. J. Radiat. Oncol. Biol. Phys. 1995, 31:57-64.
102. Weshler Z., Raz A., Rosenmann E., Weinman E., Biran S., Fuks Z., Eldor A. The effects of ionizing irradiation on production of thromboxane and prostacyclin by the isolated perfused rat kidney. In Vivo 1988, 2:289-293.
103. te Poele J.A., van Kleef E.M., van der Wal A.F., Dewit L.G., Stewart F.A. Radiation-induced glomerular thrombus formation and nephropathy are not prevented by the ADP receptor antagonist clopidogrel. Int. J. Radiat. Oncol. Biol. Phys. 2001, 50:1332-1338.
104. van Kleef E., Verheij M., te Poele H., Oussoren Y., Dewit L., Stewart F. In vitro and in vivo expression of endothelial von Willebrand factor and leukocyte accumulation after fractionated irradiation. Radiat. Res. 2000, 154:375-381.
105. Gabriels K., Hoving S., Seemann I., Visser N.L., Gijbels M.J., Pol J.F., Daemen M.J., Stewart F.A., Heeneman S. Local heart irradiation of ApoE(-/-) mice induces microvascular and endocardial damage and accelerates coronary atherosclerosis. Radiother. Oncol. 2012, 105:358-364.
106. Boerma M., Wang J., Wondergem J., Joseph J., Qiu X., Kennedy R.H., Hauer-Jensen M. Influence of mast cells on structural and functional manifestations of radiation-induced heart disease. Cancer Res. 2005, 65:3100-3107.
107. Dimitrijevic-Bussod M., Balzaretti-Maggi V.S., Gadbois D.M. Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts. Cancer Res. 1999, 59:4843-4847.
108. Lara P.C., Russell N.S., Smolders I.J., Bartelink H., Begg A.C., Coco-Martin J.M. Radiation-induced differentiation of human skin fibroblasts: relationship with cell survival and collagen production. Int. J. Radiat. Biol. 1996, 70:683-692.
109. Russell N.S., Lara P.C., Grummels A., Hart A.A., Coco-Martin J.M., Bartelink H., Begg A.C. In vitro differentiation characteristics of human skin fibroblasts: correlations with radiotherapy-induced breast fibrosis in patients. Int. J. Radiat. Biol. 2000, 76:231-240.
110. Kruse J.J., Zurcher C., Strootman E.G., Bart C.I., Schlagwein N., Leer J.W., Wondergem J. Structural changes in the auricles of the rat heart after local ionizing irradiation. Radiother. Oncol. 2001, 58:303-311.
111. Burger A., Loffler H., Bamberg M., Rodemann H.P. Molecular and cellular basis of radiation fibrosis. Int. J. Radiat. Biol. 1998, 73:401-408.
112. Evans R.A., Tian Y.C., Steadman R., Phillips A.O. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp. Cell Res. 2003, 282:90-100.
113. Hilbers F.S., Boekel N.B., van den Broek A.J., van Hien R., Cornelissen S., Aleman B.M., van't Veer L.J., van Leeuwen F.E., Schmidt M.K. Genetic variants in TGFbeta-1 and PAI-1 as possible risk factors for cardiovascular disease after radiotherapy for breast cancer. Radiother. Oncol. 2012, 102:115-121.
114. Lu Y., Boer J.M., Barsova R.M., Favorova O., Goel A., Muller M., Feskens E.J., PROCARDIS CARDIoGRAM Consortium, et al. PROCARDIS CARDIoGRAM TGFB1 genetic polymorphisms and coronary heart disease risk: a meta-analysis. BMC Med. Genet. 2012, 13:39. 10.1186/1471-2350-13-39.
115. Ehret G.B., Munroe P.B., Rice K.M., Bochud M., Johnson A.D., Chasman D.J., et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 2011, 478:103-109.
116. Havulinna A.S., Kettunen J., Ukkola O., Osmond C., Eriksson J.G., Kesaniemi Y.A., Jula A., Peltonen L., Kontula K., Salomaa V., Newton-Cheh C. A blood pressure genetic risk score is a significant predictor of incident cardiovascular events in 32,669 individuals. Hypertension 2013, 61:987-994.
117. Monceau V., Pasinetti N., Schupp C., Pouzoulet F., Opolon P., Vozenin M.C. Modulation of the Rho/ROCK pathway in heart and lung after thorax irradiation reveals targets to improve normal tissue toxicity. Curr. Drug Targets 2010, 11:1395-1404.
118. Heeneman S., Cleutjens J.P., Faber B.C., Creemers E.E., van Suylen R.J., Lutgens E., Cleutjens K.B., Daemen M.J. The dynamic extracellular matrix: intervention strategies during heart failure and atherosclerosis. J. Pathol. 2003, 200:516-525.
119. Heidenreich P.A., Schnittger I., Strauss H.W., Vagelos R.H., Lee B.K., Mariscal C.S., Tate D.J., Horning S.J., Hoppe R.T., Hancock S.L. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease. J. Clin. Oncol. 2007, 25:43-49.
120. Nadlonek N.A., Weyant M.J., Yu J.A., Cleveland J.C., Reece T.B., Meng X., Fullerton D.A. Radiation induces osteogenesis in human aortic valve interstitial cells. J. Thorac. Cardiovasc. Surg. 2012, 144:1466-1470.
121. Verheij M., Stewart F.A., Oussoren Y., Weening J.J., Dewit L.L. Amelioration of radiation nephropathy by acetylsalicylic acid. Int. J. Radiat. Biol. 1995, 67:587-596.
122. Sera N., Hida A., Imaizumi M., Nakashima E., Akahoshi M. The association between chronic kidney disease and cardiovascular disease risk factors in atomic bomb survivors. Radiat. Res. 2013, 179:46-52.
123. Ghobadi G., Bartelds B., van der Veen S.J., Dickinson M.G., Brandenburg S., Berger R.M., Langendijk J.A., Coppes R.P., van Luijk P.P. Lung irradiation induces pulmonary vascular remodelling resembling pulmonary arterial hypertension. Thorax 2012, 67:334-341.
124. Ghobadi G., van der Veen S., Bartelds B., de Boer R.A., Dickinson M.G., de Jong J.R., Faber H., Niemantsverdriet M., Brandenburg S., Berger R.M., Langendijk J.A., Coppes R.P., van Luijk P. Physiological interaction of heart and lung in thoracic irradiation. Int. J. Radiat. Oncol. Biol. Phys. 2012, 84:e639-e646. 10.1016/j.ijrobp.2012.07.2362.
125. Lara-Pezzi E., Dopazo A., Manzanares M. Understanding cardiovascular disease: a journey through the genome (and what we found there). Dis. Model. Mech. 2012, 5:434-443.
126. O'Donnell C.J., Nabel E.G. Genomics of cardiovascular disease. N. Engl. J. Med. 2011, 365:2098-2109.
127. Little M.P., Wakeford R., Lubin J.H., Kendall G.M. The statistical power of epidemiological studies analyzing the relationship between exposure to ionizing radiation and cancer, with special reference to childhood leukemia and natural background radiation. Radiat. Res. 2010, 174:387-402.
128. Land C.E. Estimating cancer risks from low doses of ionizing radiation. Science 1980, 209:1197-1203.
129. United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR) UNSCEAR 2006 Report. Annex A. Epidemiological Studies of Radiation and Cancer 2008, 13-322. United Nations, New York.
130. Tzoulaki I., Murray G.D., Price J.F., Smith F.B., Lee A.J., Rumley A., Lowe G.D., Fowkes F.G. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am. J. Epidemiol. 2006, 163:334-341.
131. Floyd J.D., Nguyen D.T., Lobins R.L., Bashir Q., Doll D.C., Perry M.C. Cardiotoxicity of cancer therapy. J. Clin. Oncol. 2005, 23:7685-7696.
132. Degteva M.O., Shagina N.B., Tolstykh E.I., Bougrov N.G., Zalyapin V.I., Anspaugh L.R., Napier B.A. An approach to reduction of uncertainties in internal doses reconstructed for the Techa River population. Radiat. Prot. Dosim. 2007, 127:480-485.
133. Likhtarov I., Thomas G., Kovgan L., Masiuk S., Chepurny M., Ivanova O., Gerasymenko V., Tronko M., Bogdanova T., Bouville A. Reconstruction of individual thyroid doses to the Ukrainian subjects enrolled in the Chernobyl Tissue Bank. Radiat. Prot. Dosim. 2013, 156:407-423.
134. Lundell M., Mattsson A., Karlsson P., Holmberg E., Gustafsson A., Holm L.E. Breast cancer risk after radiotherapy in infancy: a pooled analysis of two Swedish cohorts of 17,202 infants. Radiat. Res. 1999, 151:626-632.
135. Libby P., Ridker P.M., Hansson G.K. Progress and challenges in translating the biology of atherosclerosis. Nature 2011, 473:317-325.